Search Results - Norbert Klause
- Showing 1 - 2 results of 2
-
1
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor by Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, Dominic D. Wand, Thomas Philipp, Heike Bruck
Published 2010Artigo -
2
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the Ger... by Jan T. Kielstein, Gernot Beutel, Susanne Fleig, Jürgen Steinhoff, Tobias Meyer, Carsten Hafer, Uwe Kuhlmann, Jörn Bramstedt, Ulf Panzer, Martin Vischedyk, Veit Busch, W Ries, Steffen Mitzner, Stefan Mees, Sylvia Stracke, Jens Nürnberger, Peter Gerke, Monika Wiesner, B Sucké, Miriam Abu-Tair, Andreas Kribben, Norbert Klause, Ralf Schindler, Frank Merkel, Sabine Schnatter, Eiske M. Dorresteijn, Ola Samuelsson, R. Brunkhorst
Published 2012Artigo
Search Tools:
Related Subjects
Creatinine
Internal medicine
Medicine
Area under the curve
Atrial fibrillation
Biochemistry
Chemistry
Complement system
Dialysis
Eculizumab
Escherichia coli
Gastroenterology
Gene
Haemolysis
Haemolytic-uraemic syndrome
Hemodialysis
Immune system
Immunology
Pediatrics
Pharmacodynamics
Pharmacokinetics
Pharmacology
Renal function
Rivaroxaban
Urology
Warfarin